Second-line treatment of metastatic colorectal cancer with HR070803 in combination with 5-FU/LV and BP102

ABSTRACT: Interventions: experimental group:HR0708035, FU/LV and BP102 Primary outcome(s): Objective response rate Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 113472 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR